KRAS is the most commonly mutated oncogene in human cancer. Most KRAS-mutant cancers depend on sustained expression and signaling of KRAS, thus making it a high-priority therapeutic target. Unfortunately, development of direct small molecule inhibitors of KRAS function has been challenging. An...
News & Publications
OCG is committed to sharing its research with the community. Stay informed by reading the latest news & publications and subscribing to the OCG e-Newsletter.
In the News
Publications
CTD²
Cold Spring Harbor Perspectives in Medicine
CTD²
eLife
Alternative splicing of mRNA precursors represents a key gene expression regulatory step and permits the generation of distinct protein products with diverse functions. In a genome-scale expression screen for inducers of the epithelial-to-mesenchymal transition (EMT), we found a striking...
e-Newsletter
Issue 19, August, 2018
OCG Perspective
OCG Staff
Last updated: May 15, 2013